PBAC recommends new NIP adult vaccine listings
New Pharmaceutical Benefits Advisory Committee (PBAC) recommendations could significantly change who can access funded COVID-19 and RSV vaccines.
At its December 2025 meeting, PBAC considered...
These are the reasons people misuse prescription opioids
Contrary to the belief that people who misuse prescription opioids are doing the wrong thing, a recent Australian study has shown most people overuse opioids to manage symptoms such as pain and mental health conditions.
High interruption rates threaten patient safety
New research has found that pharmacists are interrupted at alarming rates when dispensing medicines.
Led by Monash University’s Faculty of Pharmacy and Pharmaceutical Sciences, the...
FAQ: clozapine’s close checks
Clozapine, used for the management of treatment-resistant schizophrenia, is subject to strict regulatory and monitoring requirements.
What pharmacists need to know about new prescribing pilots
On 19 February, NSW Premier Dominic Perrottet announced that a proposed pharmacist prescribing pilot would go ahead.
Intranasal naloxone spray could reduce opioid-related deaths
Naloxone has long been used by emergency responders in cases of known or suspected opioid overdose. It has been accessible over-the-counter (OTC) in an...
